Cargando…
Hydroxychloroquine: Aggravation of myasthenia gravis following off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486148/ http://dx.doi.org/10.1007/s40278-020-83244-4 |
Ejemplares similares
-
MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Bhaskar, Shalini, et al.
Publicado: (2022) -
Multiple drugs: Exacerbation of myasthenia gravis following off-label use and COVID-19 infection: 3 case reports
Publicado: (2020) -
Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020) -
Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021) -
Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)